We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Amryt Pharma Plc | LSE:AMYT | London | Ordinary Share | GB00BKLTQ412 | ORD 6P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 143.00 | 151.00 | 170.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAMYT
RNS Number : 0844F
Euronext Dublin
11 July 2019
CORPORATE EVENT NOTICE: Suspension Notice Amryt Pharma Plc LOCATION: Dublin DATE: 11th July 2019 MARKET: Euronext Growth
Trading of the under-mentioned securities of Amryt Pharma Plc have been temporarily suspended, as detailed below.
Date and time of 2019-07-11T08:00:00Z the communication Action type Suspension of trading ---------------------------------------------- Reasons for the action Admission Document in respect of the enlarged entity pending publication, in accordance with Euronext Growth Dublin rule 5.19 ---------------------------------------------- Effective from 2019-07-11T08:00:00Z ---------------------------------------------- Effective to ---------------------------------------------- Ongoing True ---------------------------------------------- Trading venue(s) XESM ---------------------------------------------- Issuer name Amryt Pharma Plc ---------------------------------------------- Issuer Legal Entity 213800BOS8WAJO2BEQ38 Identifier (LEI) ---------------------------------------------- Instrument identifier GB00BKB1MS30 (ISIN) ---------------------------------------------- Instrument full name Ordinary Shares ---------------------------------------------- Sufficiently related derivatives ---------------------------------------------- Other related instruments ---------------------------------------------- Comments ----------------------------------------------
This announcement has been issued through the Companies Announcement Service of Euronext Dublin.
The present notice and the contents thereof are only provided for information purposes in order to facilitate the fair, orderly and efficient functioning of the market and is not a recommendation to engage in investment activities. The contents of this notice are provided "as is" based on information provided to the market operator without representation or warranty of any kind. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this notice shall form the basis of any contract. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext's subsidiaries shall depend solely on the applicable rules of the market operator.
The Euronext Markets comprise the markets operated by Euronext Amsterdam, Euronext Brussels, Euronext Dublin, Euronext Lisbon, Euronext Paris and Euronext UK Markets, referred to respectively as the Amsterdam, Brussels, Dublin, Lisbon, Paris and London markets, as relevant.
Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at https://www.euronext.com/terms-use.
(c) 2019 Euronext N.V. - All rights reserved
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ISEKBLBFKDFBBBE
(END) Dow Jones Newswires
July 11, 2019 03:01 ET (07:01 GMT)
1 Year Amryt Pharma Chart |
1 Month Amryt Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions